These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10234883)

  • 21. In silico toxicology for the pharmaceutical sciences.
    Valerio LG
    Toxicol Appl Pharmacol; 2009 Dec; 241(3):356-70. PubMed ID: 19716836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A procedure for developing risk-based reference doses.
    Gaylor DW; Kodell RL
    Regul Toxicol Pharmacol; 2002 Apr; 35(2 Pt 1):137-41. PubMed ID: 12051999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Precision of estimates of an ADI (or TDI or PTWI).
    Speijers GJ
    Regul Toxicol Pharmacol; 1999 Oct; 30(2 Pt 2):S87-93. PubMed ID: 10597619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The effect of ecoestrogens on the development of the mammalian reproductive system].
    Amstislavskiĭ SIa; Eroshenko VP
    Ontogenez; 2000; 31(3):165-77. PubMed ID: 10867931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Sensitivity of the primordia of various organs to chemical substances].
    Puchkov VF; Peterka M; Elinek R; Chebotar' NA
    Arkh Anat Gistol Embriol; 1987 Jun; 92(6):13-6. PubMed ID: 3632358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How can toxicogenomics inform risk assessment?
    Oberemm A; Onyon L; Gundert-Remy U
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):592-8. PubMed ID: 15990130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Appropriate use of animal models in the assessment of risk during prenatal development: an illustration using inorganic arsenic.
    Holson JF; Desesso JM; Jacobson CF; Farr CH
    Teratology; 2000 Jul; 62(1):51-71. PubMed ID: 10861633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing the risks of exposures to multiple chemicals with a common mechanism of toxicity: how to cumulate?
    Wilkinson CF; Christoph GR; Julien E; Kelley JM; Kronenberg J; McCarthy J; Reiss R
    Regul Toxicol Pharmacol; 2000 Feb; 31(1):30-43. PubMed ID: 10715222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Different embryo-fetal toxicity effects for three VLA-4 antagonists.
    Crofts F; Pino M; DeLise B; Guittin P; Barbellion S; Brunel P; Potdevin S; Bergmann B; Hofmann T; Lerman S; Clark RL
    Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):55-68. PubMed ID: 15098199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mode of action as a determining factor in additivity models for chemical mixture risk assessment.
    Lambert JC; Lipscomb JC
    Regul Toxicol Pharmacol; 2007 Dec; 49(3):183-94. PubMed ID: 17804132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toxicity of binary mixtures of metals and pyrethroid insecticides to Daphnia magna Straus. Implications for multi-substance risks assessment.
    Barata C; Baird DJ; Nogueira AJ; Soares AM; Riva MC
    Aquat Toxicol; 2006 Jun; 78(1):1-14. PubMed ID: 16510198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interactions in the tumor-promoting activity of carbon tetrachloride, trichloroacetate, and dichloroacetate in the liver of male B6C3F1 mice.
    Bull RJ; Sasser LB; Lei XC
    Toxicology; 2004 Jul; 199(2-3):169-83. PubMed ID: 15147791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systems toxicology: applications of toxicogenomics, transcriptomics, proteomics and metabolomics in toxicology.
    Heijne WH; Kienhuis AS; van Ommen B; Stierum RH; Groten JP
    Expert Rev Proteomics; 2005 Oct; 2(5):767-80. PubMed ID: 16209655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Can exposure to low doses have effects?].
    Apostoli P; Manno M
    G Ital Med Lav Ergon; 2003; 25(3):310-9. PubMed ID: 14582248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurotoxicology risk assessment guidelines: developmental neurotoxicology.
    Tilson HA
    Neurotoxicology; 2000; 21(1-2):189-94. PubMed ID: 10794399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment factors--applications in health risk assessment of chemicals.
    Falk-Filipsson A; Hanberg A; Victorin K; Warholm M; Wallén M
    Environ Res; 2007 May; 104(1):108-27. PubMed ID: 17166493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Children as a sensitive subgroup and their role in regulatory toxicology: DGPT workshop report.
    Schwenk M; Gundert-Remy U; Heinemeyer G; Olejniczak K; Stahlmann R; Kaufmann W; Bolt HM; Greim H; von Keutz E; Gelbke HP;
    Arch Toxicol; 2003 Jan; 77(1):2-6. PubMed ID: 12491033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Viewpoint: using gene-environment interactions to dissect the effects of complex mixtures.
    Thomas DC
    J Expo Sci Environ Epidemiol; 2007 Dec; 17 Suppl 2():S71-4. PubMed ID: 18079767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.
    Thybaud V; Aardema M; Clements J; Dearfield K; Galloway S; Hayashi M; Jacobson-Kram D; Kirkland D; MacGregor JT; Marzin D; Ohyama W; Schuler M; Suzuki H; Zeiger E;
    Mutat Res; 2007 Feb; 627(1):41-58. PubMed ID: 17126066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.